Replies to post #26987 on Regen BioPharma Inc (RGBP)

[cvinvestor]

Ok, got it.

Here's a concern, if neither T. or C. Ichim is employed anymore by RGBP, then RGBP no longer has an in house scientist to carry ongoing research forward and we are back in the pre 2015 scenario which concerns me.

Granted, the relationship with NIH / NCATS and Dr. Kesari under contract to perform testing on DCellVax and maybe tCellVax is great, but without an internal scientist doing other day to day research coordination, I think the company will not have the same potential of bringing all this forward in an efficient manner. And the loss of the two scientists whose research and IP led to the current pipeline is not an encouraging sign.